Philips turns in a profit but China, tariffs weigh

Philips turns in a profit but China, tariffs weigh

Philips gets into the green
Philips gets into the green. Photo: Sem van der Wal / ANP/AFP
Source: AFP

Dutch medical device maker Philips reported a net profit for the first time in three quarters Tuesday despite weak sales in China but warned of "intensified" uncertainties due to tariffs.

Net profits came in at 72 million euros ($82 million), compared to a net loss of 998 million euros in the same quarter last year and 333 million euros in the fourth quarter of 2024.

"It's an encouraging start to the year," the firm's chief executive Roy Jakobs told reporters.

Jakobs predicted that the second half of the year would be stronger for the firm than the first half.

"In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control," he added.

The company estimated a hit of between 250-300 million euros from tariffs over the year.

Philips maintained its forecast for between one and three percent growth in sales for 2025, but slightly cut its projection for earnings before special items (EBITA).

Read also

Ford sees $1.5 bn tariff hit this year, suspends 2025 forecast

The firm pointed to a two-percent growth in orders globally, with China again proving a drag. Without China, the order growth would have been four percent, Philips said.

However, global sales were down two percent compared to the same quarter last year due to a "double-digit decline" in China, the firm said.

Philips has previous warned that a slowing Chinese economy was hurting consumer demand for products and the government's anti-corruption drive was hitting procurement.

Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.

Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.

Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.

Read also

German chemical giant BASF keeps outlook, warns on tariffs

In April 2024, it announced it had reached a $1.1 billion deal to settle US lawsuits over the faulty machines.

PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy!

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.